COVID-19: how EMA fast-tracks development support and approval of medicines and vaccines

The European Medicines Agency has published this overview of how it will accelerate its regulatory procedures so that marketing authorisations of safe, effective and high-quality COVID-19 related medicines can be granted as soon as possible.


European Medicines Agency